Thanks to the EURIPRED project it became possible to build a new infrastructure VIPRD EXTRANET platform that permits a close collaboration between scientists from different countries and backgrounds. Currently 45 research institutions worldwide subscribed to the platform whose aim is to coordinate and integrate international resources into a single specialised infrastructure to support European HIV, TB, malaria and hepatitis virus studies from early drug, vaccine and microbicide discovery to clinical trials. The platform also called the Virtual Institute creates partnerships between European scientists and international research teams from disease endemic countries and supports strong collaborations between industry and public sector research. The Virtual Institute on PRD enables multiple communities of researchers to establish efficient communication in a protected environment, to set up common tasks, monitor their execution, to participate in on-line learning activities, to disseminate results to large audiences of buy-ins, to have an access to digital library, just to name a few characteristics of the VIPRD.
Networking Monitor: February 2016
The ultimate aim of the VI is to abolish high fragmentation in the PRD research landscape that largely stalls the progress towards new vaccines and drugs. This will improve the EU's competitiveness in poverty related diseases research field and will boost our fundamental knowledge to combat PRDs that alone account for more than six million deaths worldwide every year.
HIV Research Networks
TB Research Networks
HEPATITIS Research Networks
MALARIA Research Networks
Links with major PRD scientific societies
Networking Monitor: February 2016
